Pharmaceutical compositions of a combination of metformin and a dipeptidyl peptidase-IV inhibitor

Details for Australian Patent Application No. 2009220444 (hide)

Owner Merck Sharp & Dohme Corp.

Inventors Pourkavoos, Nazaneen

Agent Spruson & Ferguson

Pub. Number AU-A-2009220444

PCT Pub. Number WO2009/111200

Priority 61/068,016 04.03.08 US

Filing date 23 February 2009

Wipo publication date 11 September 2009

International Classifications

A01N 37/52 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids - containing groups, e.g. carboxylic acid amidines

A61K 9/22 (2006.01) Medicinal preparations characterised by special physical form - Sustained or differential release type

A61K 31/155 (2006.01) - Amidines (), e.g. guanidine (HNC(NH)NH), isourea (HNC(OH)NH), isothiourea (HNC(SH)NH)

Event Publications

2 September 2010 PCT application entered the National Phase

  PCT publication WO2009/111200 Priority application(s): WO2009/111200

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009220458-Hexahydrocyclopentyl[f]findazole sulfonamides and derivates thereof as selective glucocorticoid receptor modulators

2009220439-Secure browser-based applications